Bill

Bill > S1603


MA S1603

MA S1603
To conduct a public health study of synthetic drugs in the commonwealth


summary

Introduced
02/27/2025
In Committee
02/27/2025
Crossed Over
Passed
Dead

Introduced Session

194th General Court

Bill Summary

For legislation to conduct a public health study of synthetic drugs in the commonwealth. Public Health.

AI Summary

This bill directs the Massachusetts Department of Public Health to conduct a comprehensive study on synthetic drugs, broadly defined to include substances like synthetic opioids, fentanyl, carfentanil, synthetic cocaine, bath salts, MDMA, synthetic marijuana, and synthetic psychedelics. The study will investigate the use, effects, prevalence, and health implications of these substances within the Commonwealth, focusing on collecting detailed data about historical usage rates and the physical, mental, and emotional short and long-term impacts of these drugs. Additionally, the department is tasked with developing strategic and legislative recommendations to reduce synthetic drug use, which may include public awareness campaigns, educational programs, and rehabilitative therapies. The bill requires the department to file a comprehensive report with the Senate and House of Representatives by December 1, 2026, including their findings and draft legislation to address the synthetic drug issue. This study aims to provide a thorough understanding of synthetic drug challenges and propose evidence-based solutions to mitigate their harmful effects.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see S2790 (on 12/04/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location
State Bill Page https://malegislature.gov/Bills/194/S1603
BillText https://malegislature.gov/Bills/194/S1603.pdf
Loading...